Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...

The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...

Twice-yearly injectables might soon be available to help prevent HIV infection. The injectable Sunlenca is even more ...

The drug called lenacapavir is already sold under the brand name Sunlenca to treat HIV infections in the U.S., Canada, Europe and elsewhere. The company plans to seek authorization soon for ...

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

Kenya’s ministry of health has approved the nationwide roll out of a vaginal ring to help women protect themselves from HIV.

Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching ...

A deal that allows manufacturers to produce generic versions of lenacapavir has left out some Eastern European countries ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination, ...

In two mid-Michigan school districts where the HIV education curriculum was discovered to be out of date a year ago by 6 News ...